Triamcinelone acetonide

DRUG2 trials

Sponsors

Novartis Pharmaceuticals, Cairo University

Conditions

Acute Gouty ArthritisTreatment of Minor Aphthous Ulcers

Phase 3

Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease

WithdrawnNCT01593527

Novartis PharmaceuticalsAcute Gouty Arthritis

Start: 2012-09-30End: 2012-09-30Updated: 2017-04-20

Phase 4

Evaluation of Topical Probiotic Gel Versus Triamcinolone in Minor Recurrent Aphthous Ulcers

CompletedNCT07672730

Cairo UniversityTreatment of Minor Aphthous Ulcers

Start: 2026-02-20End: 2026-04-20Updated: 2026-06-29